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A genome-wide association study 
identified a novel genetic loci 
STON1-GTF2A1L/LHCGR/FSHR 
for bilaterality of neovascular age-
related macular degeneration
Kyoko Kawashima-Kumagai1, Kenji Yamashiro  1, Munemitsu Yoshikawa1,2, Masahiro 
Miyake1,2, Gemmy Cheung Chui Ming  3, Qiao Fan3, Jia Yu Koh  3, Masaaki Saito4, Masako 
Sugahara-Kuroda1, Maho Oishi1, Yumiko Akagi-Kurashige1, Isao Nakata1, Hideo Nakanishi1, 
Norimoto Gotoh2, Akio Oishi1, Hiroshi Tamura  1, Sotaro Ooto1, Akitaka Tsujikawa1,5, 
Yasuo Kurimoto6, Tetsuju Sekiryu4, Fumihiko Matsuda2, Chiea-Chuen Khor  3,7,8, Ching-Yu 
Cheng3,9,10, Tien Yin Wong3,7,9,10 & Nagahisa Yoshimura1
Bilateral neovascular age-related macular degeneration (AMD) causes much more handicaps for 
patients than unilateral neovascular AMD. Although several AMD-susceptibility genes have been 
evaluated for their associations to bilaterality, genome-wide association study (GWAS) on bilaterality 
has been rarely reported. In the present study, we performed GWAS using neovascular AMD cases in 
East Asian. The discovery stage compared 581,252 single nucleotide polymorphisms (SNPs) between 
803 unilateral and 321 bilateral Japanese cases but no SNP showed genome-wide significance, while 
SNPs at six regions showed P-value < 1.0 × 10−5, STON1-GTF2A1L/LHCGR/FSHR, PLXNA1, CTNNA3, 
ARMS2/HTRA1, LHFP, and FLJ38725. The first replication study for these six regions comparing 36 
bilateral and 132 unilateral Japanese cases confirmed significant associations of rs4482537 (STON1-
GTF2A1L/LHCGR/FSHR), rs2284665 (ARMS2/HTRA1), and rs8002574 (LHFP) to bilaterality. In the 
second replication study comparing 24 bilateral and 78 unilateral cases from Singapore, rs4482537 
(STON1-GTF2A1L/LHCGR/FSHR) only showed significant association. Meta-analysis of discovery and 
replication studies confirmed genome-wide level significant association (P = 2.61 × 10−9) of rs4482537 
(STON1-GTF2A1L/LHCGR/FSHR) and strong associations (P = 5.76 × 10−7 and 9.73 × 10−7, respectively) 
of rs2284665 (ARMS2/HTRA1) and rs8002574 (LHFP). Our GWAS for neovascular AMD bilaterality found 
new genetic loci STON1-GTF2A1L/LHCGR/FSHR and confirmed the previously reported association of 
ARMS2/HTRA1.
Age-related macular degeneration (AMD) is one of the major causes of visual impairment in developed countries. 
Although early stage AMD does not affect visual function, late stage AMD induces severe visual loss. AMD is a 
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complex disease caused by multiple environmental and genetic risk factors. Previous genome-wide association 
studies (GWASs) identified two major susceptibility loci for AMD; complement factor H (CFH) and age-related 
maculopathy susceptibility 2/high temperature requirement A1 (ARMS2/HTRA1). Recently, AMD Gene 
Consortium performed meta-analysis of GWASs and found 34 loci were associated with AMD development1. 
Furthermore, GWASs in East Asian populations revealed new loci for AMD and suggested ethnic differences in 
susceptibility to AMD2, 3.
Compared with patients with unilateral late AMD, patients with bilateral late AMD are more prone to visual 
handicaps. The prevalence of bilateral AMD was reported to be 40–50% in Caucasian and 10–20% in Asian4–10. 
Previous studies investigated the association between bilaterality of AMD and the known AMD susceptibility 
loci. Several studies reported that ARMS2/HTRA1 contributes to the bilaterality of late AMD10–16. In contrast, 
it is still controversial whether CFH increases the risk of AMD bilaterality10, 12–14, 16–19. To identify the genetic 
determinants associated with bilaterality of late AMD in East Asian, we conducted a GWAS comparing bilateral 
late AMD patients with unilateral late AMD patients. Since most late AMD is neovascular AMD (wet type) in 
East Asian and geographic atrophy (dry type) is rare, we focused on only neovascular AMD. After finding genes 
associated with the bilaterality of neovascular AMD, we confirmed their susceptibility to AMD occurrence by 
comparing all neovascular AMD cases including both bilateral cases and unilateral cases with controls of Japanese 
general populations.
Results
Japanese patients with neovascular AMD were recruited at the Center for Macular Diseases of Kyoto University 
Hospital (n = 821) and Fukushima Medical University (n = 333) for the discovery stage. From these 1154 cases, 
10 cases were excluded due to lack of detailed fundus examination of the fellow eye and 20 cases were excluded 
because of the quality control for their genotype count analysis. Of the 1124 cases analyzed in the discovery 
stage, 803 had unilateral neovascular AMD and 321 had bilateral neovascular AMD. Subtypes of AMD were 
Bilateral neovascular AMD Unilateral neovascular AMD P-value
n Age Sex (%, male) n Age Sex (%, male) Age Sex
Discovery stage
Kyoto 247 80.9 ± 7.8 70.5 546 76.4 ± 8.4 69.6 <0.001 0.81
Fukushima 74 81.6 ± 6.3 83.8 257 77.6 ± 7.9 75.1 <0.001 0.12
Total 321 81.1 ± 7.4 73.5 803 76.8 ± 8.3 71.4 <0.001 0.47
Replication stage
Kobe 36 83.4 ± 7.0 77.8 132 77.4 ± 8.0 71.2 <0.001 0.43
Singapore 24 71.6 ± 5.9 70.8 78 66.0 ± 10.2 61.5 0.0013 0.56
Table 1. Neovascular age-related macular degeneration samples used in the study
Figure 1. Minus log-transformed P-values are shown in a signal intensity (Manhattan) plot relative to their 
genomic position for bilaterality of age-related macular degeneration. P-values are adjusted for age and sex.
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typical AMD in 507 patients and PCV in 617 patients. Clinical features of subjects are summarized in Table 1. 
Patients with bilateral neovascular AMD were older than patients with unilateral neovascular AMD (P < 0.001). 
While 70–80% of patients were male, the percentages were similar between bilateral and unilateral groups. The 
number of SNPs evaluated after quality control was 581,252. We plotted our genome-wide association findings 
on quantile-quantile (QQ) plots, and genomic control method revealed only a slight inflation of the test statistics 
(Inflation factor λ = 1.01).
Results of the genome-wide association analysis are shown in Fig. 1. Although no chromosomal loci showed 
genome-wide significance, fourteen SNPs showed P-value < 1.0 × 10−5; 7 SNPs in STON1-GTF2A1L/LHCGR/
FSHR region, 1 SNP in PLXNA1, 2 SNPs in CTNNA3, 1 SNP in ARMS2/HTRA1, 1 SNP in LHFP, and 2 SNPs 
near FLJ38725 (Table 2). No SNPs in CFH showed significant association with bilaterality of neovascular AMD 
(P > 0.05). Supplementary Table 1 shows the association between the AMD bilaterality and the analyzed 440 
SNPs within 10 genes for which associations with AMD were verified in Asian individuals. Although rs11963725 
of C2/CFB (P = 0.0124), rs1054060 of C3 (P = 0.0454), rs17310296 of CETP (P = 0.00250), rs4714699 of VEGFA 
(P = 0.0368), rs6822976 of CFI (P = 0.00256), and rs12638651 of ADAMTS9 (P = 0.00742) showed nominally 
significant associations, these associations should be interpreted as negative results after permutation tests.
One representative SNP from each of these six loci was examined in the replication studies (Table 3). For 
the first replication stage, Japanese patients with neovascular AMD were recruited at Kobe City Medical Center 
General Hospital (n = 170). Two cases were excluded after quality control for the genotype count analysis, and 
the genotypes of 36 bilateral AMD and 132 unilateral AMD were compared. The associations with neovascular 
AMD bilaterality were confirmed in rs4482537 of STON1-GTF2A1L/LHCGR/FSHR (P = 4.97 × 10−2), rs2284665 
of ARMS2/HTRA1 (P = 3.83 × 10−2), and rs8002574 of LHFP (P = 3.66 × 10−2). For the second replication stage, 
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Table 2. Results of discovery study for the 14 SNPs that showed P-value < 10−5, comparing bilateral 
neovascular age-related macular degeneration cases with unilateral those. SNP, single nucleotide 
polymorphism; Chr, chromosome; MAF, minor allele frequency; OR, odds ratio; CI, confidence interval. 
*Adjusted for age and sex.
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Singaporean patients with neovascular AMD (n = 102) were recruited at Singapore National Eye Center. In the 
second replication study with 24 bilateral and 78 unilateral cases, only rs4482537 of STON1-GTF2A1L/LHCGR/
FSHR showed significant association (P = 3.34 × 10−2), while rs2284665 of ARMS2/HTRA1 and rs8002574 of 
LHFP showed same association direction as in the discovery stage analysis and the first replication study with 
Japanese without statistically significant P-value. The meta-analysis of discovery and replication studies con-
firmed genome-wide significant association of STON1-GTF2A1L/LHCGR/FSHR (rs4482537; P = 2.61 × 10−9) 
with bilaterality. As for ARMS2/HTRA1 and LHFP, the effect direction was same among three cohorts and 
meta-analysis further confirmed their strong associations with bilaterality (P = 5.76 × 10−7 for rs2284665 of 
ARMS2/HTRA1 and P = 9.73 × 10−7 for rs8002574 of LHFP).
To evaluate the associations of these three SNPs with the occurrence of AMD, genotypes of all neovascular 
AMD cases including both bilateral cases and unilateral cases were compared with the Nagahama cohort as 
Japanese general control (Table 4). The analysis showed that only ARMS2/HTRA1 was significantly associated 
with the occurrence of AMD (P = 1.78 × 10−81).
Discussion
In this current study, we performed GWAS on bilaterality of neovascular AMD for the first time and identi-
fied the association of new genetic loci STON1-GTF2A1L/LHCGR/FSHR with neovascular AMD bilaterality. 
ARMS2/HTRA1 could be also associated with bilaterality of neovascular AMD and the association of LHFP 
should be further investigated.
Regional association plot (Supplementary Figure 1) for the studied SNPs within STON1-GTF2A1L/
LHCGR/FSHR region did not elucidate which of these genes was correspond to the bilaterality of AMD. STON1 
encodes stonin 1. Although stonin 2 controls synaptic transmission, the function of stonin 1 has not been 
elucidated20. GTF2A1L is expressed mainly in testis to form a counterpart of general transcription factor IIA 
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Table 3. Results of two replication studies and meta-analysis for the six loci associated in discovery study, 
comparing bilateral neovascular age-related macular degeneration cases with unilateral those. SNP, single 
nucleotide polymorphism; OR, odds ratio; CI, confidence interval. *Adjusted for age and sex.
SNP Allele
Control (Nagahama cohort, 




1 2 11 12 22 AF1 11 12 22 MAF
rs4482537 (LHCGR/FSHR) C T 280 1430 1555 0.30 134 582 666 0.31 0.79 (1.01, 0.92–1.12)
rs2284665 (ARMS2/HTRA1) G T 1165 1556 544 0.60 232 567 594 0.37
1.78 × 10−81 
(0.40, 
0.36–0.44)
rs8002574 (LHFP) T C 53 690 2522 0.12 21 265 1107 0.11 0.11 (0.89, 0.78–1.03)
Table 4. Results of the association study for three loci about the occurrence of AMD, comparing all neovascular 
age-related macular degeneration cases with Japanese general population cohort. SNP, single nucleotide 
polymorphism; AF, allele frequency; MAF, minor allele frequency; OR, odds ratio; CI, confidence interval, 
*Chi-trend.
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subunit. In drosophila, transcription factor IIA regulates development of photoreceptor cells21. Polymorphisms 
in STON1-GTF2A1L might promote bilateral development of AMD through their effects on photoreceptor cells 
synaptic transmission.
LHCGR encodes luteinizing hormone/choriogonadotropin receptor, a receptor for luteinizing hormone (LH) 
and human chorionic gonadotropin (hCG), and FSHR encodes follicle-stimulating hormone receptor, a receptor 
for follicle-stimulating hormone (FSH). Both LH and FSH are released from the pituitary gland and stimulate 
estrogen secretion. Estrogen is associated with inhibition of AMD development22–24 and a previous study reported 
that polymorphisms of estrogen receptor gene were associated with AMD25. Aging decreases estrogen produc-
tion, leading to increased LH/FSH secretion in the elderly via feedback mechanism.
Age-related decrease in estrogen production and increase in LH/FSH secretion are associated, partly, 
with increased risk of atherosclerosis and heart diseases by affecting lipoprotein/cholesterol metabolism26–28. 
Considering that several genes in lipoprotein/cholesterol metabolism are associated with AMD development, 
LHCGR/FSHR would affect the bilaterality of neovascular AMD in part by altering lipoprotein/cholesterol metab-
olism. Another possibility is that LHCGR/FSHR polymorphism would have localized effect, thereby affecting 
neovascular AMD bilaterality. Müller cells and retinal pigmented epithelial cells produce hCG and cone pho-
toreceptor cells express its receptor LHCGR29. Further study on the roles of LHCGR of photoreceptor cells and 
the roles of LHCGR/FSHR-induced lipoprotein/cholesterol metabolism alteration would lead to prevention of 
neovascular AMD development in the fellow eye.
STON1-GTF2A1L/LHCGR/FSHR region also includes long intergenic noncoding RNA (lincRNA, RP11-
460M2.1). LincRNA can control gene expression and some lincRNAs might be able to control ocular neovascu-
larization30. LincRNA RP11-460M2.1 might have some ability to control bilaterality of neovascular AMD.
Although CFH is a major susceptibility gene for AMD, SNPs in CFH did not have any association with the 
bilaterality of neovascular AMD in our study. Previous studies also showed that CFH was not associated with the 
bilaterality of neovascular AMD4, 7, 10, 11. In contrast, rs4482537 in LHCGR/FSHR locus had significant association 
with the bilaterality of neovascular AMD, but not with the occurrence of AMD. On the other hand, previous 
studies and current study support that ARMS2/HTRA1 is associated with both occurrence and bilaterality of 
AMD. AMD-associated genes can be classified into three types, genes associated with both AMD occurrence and 
bilaterality, genes associated with only AMD occurrence, and genes associated with only AMD bilaterality. The 
second eye involvement in AMD might be regulated by a unique mechanism in addition to the factors associated 
with the first eye involvement.
LHFP is a HMGIC fusion partner gene in lipoma, one of the most common mesenchymal tumors31. LHFP is 
also associated with mesenchymal differentiation in gliosarcoma32. Recent studies suggest that epithelial–mesen-
chymal transition (EMT) has important roles in the development of AMD33, 34. LHFP might affect the bilateral-
ity of neovascular AMD by affecting the EMT process. LHFP is also associated with Alzheimer’s disease35 that 
shares common clinical and pathological features with AMD; both Alzheimer’s disease and AMD are preceded 
by accumulation of amyloid beta36. LHFP might affect accumulation of amyloid beta and trigger the second eye 
involvement of AMD.
Although anti-VEGF treatment has improved treatment outcome of exudative AMD, the SEVEN-UP study 
reported that 51% of the patients in their study suffered from bilateral neovascular AMD during 7 years of 
follow-up37. The second eye involvement in patients with late AMD is a matter of concern because patients with 
bilateral late AMD are more prone to visual handicaps than patients with unilateral late AMD. The SEVEN-UP 
study also suggested that reduced frequency of treatments contributed to the decline of visual acuity. Increasing 
the frequency of injection might maintain visual acuity for an extended period. Therefore intensive treatment 
should be initiated in patients with unilateral neovascular AMD who are most likely to develop bilateral neovas-
cular AMD in the future, to maintain good visual acuity. Prediction of the second eye involvement in neovascular 
AMD would be beneficial for patients with unilateral neovascular AMD. Elucidation of the mechanism to control 
the second eye involvement might lead to prevention of the second eye involvement.
The limitations of this study are its retrospective nature and relatively small sample size. Studies involving large 
size might successfully replicate the association of LHFP, and prospective study would further confirm the asso-
ciation of STON1-GTF2A1L/LHCGR/FSHR and ARMS2/HTRA1 to the bilaterality of AMD. Considering that 
CATT study could not detect any genetic associations between polymorphisms and the second eye involvement 
within 2 years of follow-up17, studies with longer follow-up period should be performed. The unilateral patients 
included in the current study were significantly younger than the bilateral patients. The unilateral patients may 
go on to develop bilateral disease with longer follow up, which would reduce the power of detecting genetic 
associations. Statistical adjustment for the time of diagnosis with unilateral neovascular AMD would also be 
helpful. Current study was performed only in Asians including both typical AMD and PCV. The prevalence of 
PCV is higher in Asian than Caucasian4–10, 38. Although the reported prevalence of bilateral involvement is similar 
between typical AMD and PCV, the ethnic difference cannot be ignored; 40–50% in Caucasian4, 5 and 10–20% 
in Asian6–10. Recent studies also suggested the role of ethnic differences in AMD genetic susceptibility3. Further 
study is needed to evaluate whether STON1-GTF2A1L/LHCGR/FSHR and LHFP are associated with neovascular 
AMD bilaterality in other races.
In conclusion, our GWAS for neovascular AMD bilaterality identified novel genetic loci STON1-GTF2A1L/
LHCGR/FSHR and confirmed the association of ARMS2/HTRA1 with the bilaterality. LHFP might also be asso-
ciated with AMD bilaterality. Prediction of the second eye involvement would be beneficial in determining the 
long-term management strategy for the first eye of AMD, and elucidation of the mechanisms for the second eye 
involvement would lead to prevention of the second eye involvement in AMD.
www.nature.com/scientificreports/
6SCIENtIFIC RepORTS | 7: 7173 | DOI:10.1038/s41598-017-07526-9
Methods
All procedures used in this study confirmed to the tenets of the Declaration of Helsinki. The Institutional Review 
Board and the Ethics Committee of each institution approved the experimental protocols; The Kyoto University 
Graduate School and Faculty of Medicine Ethics Committee, Fukushima Medical University Ethics Committee, 
Kobe City Medical Center General Hospital Ethics Committee, Singapore National Eye Center Ethics Committee, 
the Ad hoc Review Board of the Nagahama Cohort Project, and the Nagahama Municipal Review Board of 
Personal Information Protection. All the participants were fully informed of the purpose and procedures and a 
written consent was obtained from each.
Study subjects in GWAS for bilaterality. Japanese patients with neovascular AMD were recruited at 
the Center for Macular Diseases of Kyoto University Hospital (n = 821) and Fukushima Medical University 
(n = 333) for the discovery stage, and at Kobe City Medical Center General Hospital (n = 170) for the replication 
stage. Further, patients with neovascular AMD (n = 112) were recruited at Singapore National Eye Center for 
the second replication stage. All subjects underwent comprehensive ophthalmologic examinations, including 
dilated contact lens slit-lamp biomicroscopy, fundus photography, fluorescein and indocyanine green angiog-
raphy (HRA2, Heidelberg Engineering, Heidelberg, Germany), and optical coherence tomography (Spectralis 
HRA + OCT, Heidelberg Engineering, Heidelberg, Germany).
Neovascular AMD was defined as the presence of exudative AMD as described in the international classifi-
cation system for age-related maculopathy. Typical AMD involved classic choroidal neovascularization (CNV), 
occult CNV, or a combination of both. The diagnosis of polypoidal choroidal vasculopathy (PCV) was based on 
indocyanine green angiography, which showed a branching vascular network terminated in polypoidal lesions. 
Diagnosis and grading of AMD were performed in a masked manner by two ophthalmologists independently. In 
cases of disagreement, the third retinal specialist made the final decision. Bilaterality of neovascular AMD and 
subject age at final visit was used for analysis.
Genotyping. Genomic DNAs were extracted from peripheral blood leukocytes using QuickGene-610L 
DNA extraction kit (FUJIFILM Co., Tokyo, Japan). Genotyping was performed using Illumina BeadChip, both 
OmniExpress and HumanExome, HumanOmni2.5–8, or OmniExpress. The distortion of Hardy-Weinberg equi-
librium (HWE) was not considered in this study because all samples comprised AMD cases. Stringent quality 
control, including minor allele frequency (MAF) ≥ 1% and genotype call rate ≥ 95% (per SNP and per individ-
ual), was performed using PLINK ver1.07 (http://pngu.mgh.harvard.edu/~purcell/plink/).
Statistical analysis. Association between genotypic distribution of each SNP and the bilaterality of neo-
vascular AMD was examined using logistic regression analysis by adjusting for age and sex using Software R 
(R Foundation for Statistical Computing, Vienna, Austria). Inflation of the test statistics was assessed using 
the genomic-control method. SNPs with P-value < 1.0 × 10−5 were selected as candidates of replication stages. 
Among the candidate SNPs, one representative SNP was selected from each locus (r2 > 0.8 in the discovery stage 
samples) and these SNPs were tested for association in replication stages. The genotypic counts of the first and 
second stages were also evaluated in meta-analysis.
Furthermore, association between genotypic distribution of each candidate SNP of neovascular AMD bilat-
erality and the occurrence of neovascular AMD was examined by chi-square test for trend. All neovascular AMD 
cases were compared with Japanese general cohort, the Nagahama Study39, as control.
Control cohort for the AMD susceptibility test. A fixed dataset of 3,265 unrelated healthy Japanese sub-
jects from the Nagahama prospective genome cohort for the Comprehensive Human Bioscience (The Nagahama 
Study) was used as a control group in the AMD susceptibility test. In detail, a total of 3,712 individuals from 
the Nagahama study were genotyped using HumanHap610K Quad Arrays, HumanOmni2.5 M Arrays, and/
or HumanExome Arrays (Illumina Inc., CA, USA). To ensure high-quality genotype data, a series of quality 
control filters were applied to the data from each platform before imputation, including MAF cut-offs (>0.01), 
HWE (P > 1.0 × 10−6), genotypic success rate (>95%), individual call rate (>99%), and estimated relatedness 
(PI-HAT < 0.35). Quality controls were performed using PLINK (ver.1.07; http://pngu.mgh.harvard.edu/,pur-
cell/plink/). For consistent genotyping data across each platform, we performed genomic imputation on availa-
ble 1000 Genome Project data from East Asian subjects using MACH software (http://www.sph.umich.edu/csg/
abecasis/MACH/tour/imputation.html). After imputation, we again performed quality control including MAF 
cut-offs (>0.01), HWE (P > 1.0 × 10−7), genotypic success rate (>90%), individual call rate (>90%), and impu-
tation quality (R2 > 0.3).
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